Coordinator: Irini Fundulaki
According to the Precision Medicine Initiative, precision medicine is an “emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person”. Precision Medicine allows treating doctors to decide on the appropriate treatment for a patient who is suffering from a specific disease and who has a specific genotype. The Precision Medicine approach differs from the traditional approach in which the treatment of diseases follows a “one-size-fits-all” approach focusing on the average person without considering the differences exhibited by the various patients. Precision medicine is a model in which the individuals’ phenotype and genes, environment, and lifestyle are used as additional layers of patient data in disease treatment and prevention plans. All Precision Medicine strategies include the use of decision-making processes based on the use of biomarkers. Biomarkers can be used to augment and refine traditional patient data to provide a higher level of specificity for disease prevention and patient treatment and are crucial in providing the appropriate treatment to her.
In Greece we have three Precision Medicine initiatives:
The Institute of Computer Science-FORTH, participates in all the aforementioned Networks, and is the only ICT participant for GR iCARDIACNET and GR NEUROPMNET. I am the scientific lead on behalf of the Institute of Computer Science - FORTH for all the aforementioned Precision Medicine Networks.
In the context of the Hellenic Precision Medicine Network on Cancer, ICS-FORTH developed
In the context of the National Network for Genetic Cardiovascular Diseases Study And Prevention Of Sudden Death In The Young On The Basis Of Precision Medicine (GR iCARDIACNET) and National Initiative for Neurodegenerative Disease Research Based on Precision Medicine (GR DeGeNEURO NET) we developed a complete ICT Ecosystem that supports the medical and lab personnel in their daily tasks.
